OMEGA-3 fatty acids contribute to plaque stability differentially affecting the release of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human monocytes/macrophages in culture by Massaro, Marika et al.
Accepted as Oral Communication at 2nd Congress of the International Society of 
Nutrigenetics/Nutrigenomics 
October 6-8 2008, Geneva, Switzerland 
 
 
 
OMEGA-3 FATTY ACIDS CONTRIBUTE TO PLAQUE STABILITY DIFFERENTIALLY 
AFFECTING THE RELEASE OF MATRIX METALLOPROTEINASES AND TISSUE 
INHIBITORS OF METALLOPROTEINASES BY HUMAN MONOCYTES/MACROPHAGES 
IN CULTURE. 
 
Massaro M,1,2 Scoditti E2, Carluccio MA2, Storelli C,1 Distante A,2 Maritines G 4 and De Caterina, 
R2,3 
1University of Lecce, Italy  
2C.N.R. Institute of Clinical Physiology, Pisa and Lecce, Italy 
3“G. d’Annunzio” University, Chieti, Italy 
 
Objectives. High intakes of omega-3 fatty acids has been associated with protection from plaque 
rupture. The secretion of metalloproteinases (MMPs) by macrophages is believed to play a key role 
in matrix degradation underlying plaque instability. Conversely, tissue inhibitors of 
metalloproteinases (TIMPs) would contribute to plaque stability. We therefore studied the effects of 
omega-3 fatty acids on the release and activity of MMPs and TIMPs in cultured human monocytoid 
cells.  
Methods. Human U937 monocytoid cells were differentiated into macrophages by exposure for 24 
h to 30 ng/mL phorbol myristate acetate (PMA) and 10 ng/mL tumor necrosis factor(TNF)-α. Both 
monocytes and macrophages were treated for 48 h with the DHA (22:6 n-3) or EPA (22:6 n-3) (25-
100 μmol/L) before stimulation for 24 h with 10 ng/ml TNFα. Cell supernatates were used to test 
the release of gelatinase A (MMP-2), gelatinase-B (MMP-9), collagenase-1 (MMP-1), TIMP-1 and 
TIMP-2, by ELISAs, and total gelatinase and anti-gelatinase activities by zymography and retro-
zymography techniques, respectively.  
Results. The long term exposure to 50 μmol/L EPA and DHA, but not to arachidonic acid (20:4 n-
6), significantly reduced MMP-9 protein release without affecting the release of MMP-1, MMP-2 
and TIMP-1. Conversely, TIMP-2 protein release was significantly increased by EPA and DHA 
(Table). Zymography for MMP-9 and retro-zymography for TIMP-1 and -2 reproduced the same 
results.  
Conclusions. The long term exposure to omega-3 fatty acids significantly reduces MMP-9 release 
without affecting the release of MMP-1 and -2. This effect, associated with the increase of TIMP-2 
protein production and activity, may contribute to explaining the plaque-stabilizing effect by 
omega-3 fatty acid observed in humans. 
 
Table 
 
 MMP-1 MMP-2 MMP-9 TIMP-1 TIMP-2 
Control 4.6±0.5 3.0±1.0 5.0±0.8 60.0±7.0 18.5±2.1 
PMA+TNF 28.3±5.2 3.5±0.8 26.5±1.5 300.5±15.2 16.0±1.3 
DHA+PMA+TNF 25.0±3.2 3.3±0.9 12.0*±0.9 297.4±10.0 27.8*±2.1 
EPA+PMA+TNF 27.3±2.5 3.1±0.8 9.8*±1.4 295±12.4 30*±2.5 
Values are given as ng/106 cells/48h and presented as means ± standard deviation 
*P<0.05 as compared with respective control. 
 
 
 
